Literature DB >> 2671928

Castleman's disease: a well defined histological pattern for a widely divergent clinical spectrum.

M F d'Agay1, J M Miclea, J P Clauvel, G Schaison, C Brocheriou.   

Abstract

If the histological patterns of Castleman's disease are well defined--hyaline vascular type and plasma cell type--, the clinical spectrum is widely divergent, ranging from localised forms cured by surgical ablation to multicentric idiopathic forms requiring systemic therapy; some cases are associated with an acquired immunodeficiency, such as HIV infection. The pathogeny of the disease is discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2671928

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  4 in total

1.  A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients.

Authors:  Bo Ye; Shu-Geng Gao; Wang Li; Long-Hai Yang; Shou-Hua Zhao; Ke Ma; Xiao-Lei Zhu; Xiang-Yang Liu; Ke-Ling Sun
Journal:  Med Oncol       Date:  2009-11-24       Impact factor: 3.064

2.  Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.

Authors:  M C Kinney; D S Hummell; P M Villiger; A Hourigan; L Rollins-Smith; A D Glick; A R Lawton
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

3.  Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.

Authors:  Xuanye Zhang; Huilan Rao; Xiaolu Xu; Zhihua Li; Bing Liao; Hongmei Wu; Mei Li; Xiuzhen Tong; Juan Li; Qingqing Cai
Journal:  Cancer Sci       Date:  2017-12-28       Impact factor: 6.716

4.  Clinicopathological characteristics of unicentric retroperitoneal Castleman's disease: a study of 14 cases.

Authors:  Shuai Wang; Shanwen Chen; Jiangfeng Xu; Songliang Cai
Journal:  World J Surg Oncol       Date:  2016-01-06       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.